Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Baird raised the price target for CrowdStrike Holdings Inc. (NASDAQ:CRWD) from $460 to $490 while maintaining a Neutral rating. CrowdStrike Holdings shares closed at $782.17 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. lowered the price target for Fulcrum Therapeutics Inc. (NASDAQ:FULC) from $25 to $3 and downgraded the stock from Buy to Neutral. Fulcrum Therapeutics shares closed at $6.42 on Monday. See how other analysts view this stock.
- Goldman Sachs raised the price target for HP Inc. (NYSE:HPQ) from $16 to $19 while maintaining a Sell rating. HP shares closed at $29.34 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. cut the price target for Praxis Precision Medicines Inc. (NASDAQ:PRAX) from $1,250 to $1,200 and maintained a Buy rating. Praxis Precision Medicines shares closed at $335.16 on Monday. See how other analysts view this stock.
- Ascendiant Capital raised its price target for Genasys Inc. (NASDAQ:GNSS) from $5.50 to $6 and maintained a Buy rating. Genasys shares closed at $2.11 on Monday. See how other analysts view this stock.
- Goldman Sachs lowered the price target for Intuit Inc. (NASDAQ:INTU) from $519 to $276 and downgraded the stock from Neutral to Sell. Intuit shares closed at $353.76 on Monday. See how other analysts view this stock.
- Evercore ISI Group raised the price target for Guardant Health Inc. (NASDAQ:GH) from $95 to $160 and upgraded the stock from In-Line to Outperform. Guardant Health shares closed at $129.14 on Monday. See how other analysts view this stock.
- Needham increased the price target for Credo Technology Group Holding Ltd. (NASDAQ:CRDO) from $220 to $275 while maintaining a Buy rating. Credo Technology Group Holding shares closed at $226.10 on Monday. See how other analysts view this stock.
- BTIG lowered its price target for Praxis Precision Medicines Inc. (NASDAQ:PRAX) from $843 to $810 and maintained a Buy rating. Praxis Precision Medicines shares closed at $335.16 on Monday. See how other analysts view this stock.
- BofA Securities cut the price target for Nu Holdings Ltd. (NYSE:NU) from $16 to $10 and downgraded the stock from Neutral to Underperform. Nu Holdings shares closed at $12.99 on Monday. See how other analysts view this stock.
Login to comment